Cargando…

Integrated analysis of single-cell and bulk RNA sequencing data reveals a pan-cancer stemness signature predicting immunotherapy response

BACKGROUND: Although immune checkpoint inhibitor (ICI) is regarded as a breakthrough in cancer therapy, only a limited fraction of patients benefit from it. Cancer stemness can be the potential culprit in ICI resistance, but direct clinical evidence is lacking. METHODS: Publicly available scRNA-Seq...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Zhen, Wang, Zi-Xian, Chen, Yan-Xing, Wu, Hao-Xiang, Yin, Ling, Zhao, Qi, Luo, Hui-Yan, Zeng, Zhao-Lei, Qiu, Miao-Zhen, Xu, Rui-Hua
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2022
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9052621/ https://www.ncbi.nlm.nih.gov/pubmed/35488273 http://dx.doi.org/10.1186/s13073-022-01050-w

Ejemplares similares

A Pan-Cancer Analysis of Predictive Methylation Signatures of Response to Cancer Immunotherapy
por: Xu, Bingxiang, et al.
Publicado: (2021)

An integrative and comparative study of pan-cancer transcriptomes reveals distinct cancer common and specific signatures
por: Cao, Zhen, et al.
Publicado: (2016)

Integrative Analysis of Hypoxia-Associated Signature in Pan-Cancer
por: Zhang, Qian, et al.
Publicado: (2020)

Integrated Analysis of Single-Cell and Bulk RNA-Sequencing Reveals a Tissue-Resident Macrophage-Related Signature for Predicting Immunotherapy Response in Breast Cancer Patients
por: Xia, Zi-An, et al.
Publicado: (2022)

Unveiling the interplay between mutational signatures and tumor microenvironment: a pan-cancer analysis
por: Luo, Li-Zhi, et al.
Publicado: (2023)

Pan-cancer analysis of AIM2 inflammasomes with potential implications for immunotherapy in human cancer: A bulk omics research and single cell sequencing validation
por: Qin, Yan, et al.
Publicado: (2022)

Integrated in silico analysis of LRP2 mutations to immunotherapy efficacy in pan-cancer cohort
por: Li, Chunbo, et al.
Publicado: (2022)

The role of TGF-β pathway alterations in immune regulation as a potential pan-cancer biomarker in immunotherapy
por: Liang, Yan, et al.
Publicado: (2021)

Integrating single-cell and bulk RNA sequencing to predict prognosis and immunotherapy response in prostate cancer
por: Wen, Xiao Yan, et al.
Publicado: (2023)

Integrative analysis reveals a four-gene signature for predicting survival and immunotherapy response in colon cancer patients using bulk and single-cell RNA-seq data
por: Chai, Ruoyang, et al.
Publicado: (2023)

Expert opinions on immunotherapy for patients with colorectal cancer
por: Wang, Feng, et al.
Publicado: (2020)

Integrated analysis of single-cell and Bulk RNA sequencing reveals a malignancy-related signature in lung adenocarcinoma
por: Wu, Mengxi, et al.
Publicado: (2023)

Comprehensive Pan-Cancer Analysis of Senescence With Cancer Prognosis and Immunotherapy
por: Zhao, Qinfei, et al.
Publicado: (2022)

Pan-cancer analysis of SETD2 mutation and its association with the efficacy of immunotherapy
por: Lu, Mingdong, et al.
Publicado: (2021)

Pan-Cancer Analysis Revealed SRSF9 as a New Biomarker for Prognosis and Immunotherapy
por: Liu, Jinhui, et al.
Publicado: (2022)

A tumor-associated endothelial signature score model in immunotherapy and prognosis across pan-cancers
por: Chen, Shuzhao, et al.
Publicado: (2023)

Bulk RKKY signatures of topological phase transition in silicene
por: Duan, Hou-Jian, et al.
Publicado: (2018)

Pan-cancer analysis of TASL: a novel immune infiltration-related biomarker for tumor prognosis and immunotherapy response prediction
por: Li, Huanyu, et al.
Publicado: (2023)

Mast cell marker gene signature: prognosis and immunotherapy response prediction in lung adenocarcinoma through integrated scRNA-seq and bulk RNA-seq
por: Zhang, Pengpeng, et al.
Publicado: (2023)

Pan-cancer analysis of necroptosis-related gene signature for the identification of prognosis and immune significance
por: Ma, Jincheng, et al.
Publicado: (2022)

Integrated analysis of gene expression changes associated with coronary artery disease
por: Miao, Liu, et al.
Publicado: (2019)

RelB is a potential molecular biomarker for immunotherapy in human pan-cancer
por: Wu, Jintao, et al.
Publicado: (2023)

Integrated analysis of single-cell and bulk RNA-seq establishes a novel signature for prediction in gastric cancer
por: Wen, Fei, et al.
Publicado: (2023)

Pan‐cancer analysis reveals sex‐specific signatures in the tumor microenvironment
por: Han, Junwei, et al.
Publicado: (2022)

The role of Angiogenesis and remodeling (AR) associated signature for predicting prognosis and clinical outcome of immunotherapy in pan-cancer
por: Sun, Xiaojiao, et al.
Publicado: (2022)

A transcriptomic pan-cancer signature for survival prognostication and prediction of immunotherapy response based on endothelial senescence
por: Wu, Zhengquan, et al.
Publicado: (2023)

Systematic analysis reveals a pan-cancer SNHG family signature predicting prognosis and immunotherapy response
por: Zheng, Haotian, et al.
Publicado: (2023)

A pan‐cancer blueprint of genomics alterations and transcriptional regulation of Siglecs, and implications in prognosis and immunotherapy responsiveness
por: Mei, Song, et al.
Publicado: (2023)

Identification and validation of a muscle failure index to predict prognosis and immunotherapy in lung adenocarcinoma through integrated analysis of bulk and single-cell RNA sequencing data
por: Gu, Xuyu, et al.
Publicado: (2023)

Integrated Solid/Nanoporous Copper/Oxide Hybrid Bulk Electrodes for High-performance Lithium-Ion Batteries
por: Hou, Chao, et al.
Publicado: (2013)

The pan-genome and local adaptation of Arabidopsis thaliana
por: Kang, Minghui, et al.
Publicado: (2023)

An integrated pan-cancer analysis of PSAT1: A potential biomarker for survival and immunotherapy
por: Feng, Mingtao, et al.
Publicado: (2022)

Construction of EMT related prognostic signature for kidney renal clear cell carcinoma, through integrating bulk and single-cell gene expression profiles
por: Huang, Qi, et al.
Publicado: (2023)

Integration of single-cell and bulk RNA-seq to establish a predictive signature based on the differentiation trajectory of M2 macrophages in lung adenocarcinoma
por: Chen, Zhike, et al.
Publicado: (2022)

HUPAN: a pan-genome analysis pipeline for human genomes
por: Duan, Zhongqu, et al.
Publicado: (2019)

Identification of Claudin-6 as a Molecular Biomarker in Pan-Cancer Through Multiple Omics Integrative Analysis
por: Zhang, Chiyuan, et al.
Publicado: (2021)

Pan-cancer analysis of IFN-γ with possible immunotherapeutic significance: a verification of single-cell sequencing and bulk omics research
por: Wei, Xiaoying, et al.
Publicado: (2023)

A Pan-Cancer Immunogenomic Atlas for Immune Checkpoint Blockade Immunotherapy
por: Yang, Jing, et al.
Publicado: (2022)

Identification of a Recurrence Gene Signature for Ovarian Cancer Prognosis by Integrating Single-Cell RNA Sequencing and Bulk Expression Datasets
por: Zhang, Yongjian, et al.
Publicado: (2022)

Integrated clustering signature of genomic heterogeneity, stemness and tumor microenvironment predicts glioma prognosis and immunotherapy response
por: Wu, Yangyang, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_ebqhqkldllhqs87vbt3cudk173